Romina Hofele is an accomplished professional with extensive experience in the biopharmaceutical industry, currently serving as a Director at AstraZeneca since February 2019 and previously holding roles such as Associate Principal Scientist, Senior Scientist, and Scientist II. Prior experience includes positions at MedImmune from October 2015 to October 2020, where Romina contributed as Scientist II and Scientist I in the Protein Characterization Group focused on Analytical Biotechnology. Earlier roles include Scientist I at Amplimmune, Inc., and a Postdoctoral researcher and PhD student at the Max Planck Institute for Biophysical Chemistry, specializing in Bioanalytical Mass Spectrometry. Romina's career began at Sandoz as Global Analytical Development Group Leader and Analyst, followed by a tenure at Givaudan as an Analyst. Educational credentials include a PhD in Structural Biology - Mass Spectrometry from The University of Göttingen and a Licenciada in Ciencias Químicas from the University of Buenos Aires.